The Potential of Exosomes Derived from Chronic Myelogenous Leukemia Cells As Biomarker Based on the BCR-ABL mRNA Transcript

被引：0
|
作者：
Kang, Ka-Won
Jung, Jikhan
Hur, Woojune
Park, Jaena
Shin, Hyunku
Choi, ByeongHyeon
Jeong, Hyesun
Kim, Dae Sik
Yu, Eun Sang
Lee, Se Ryeon
Sung, Hwa Jung
Kim, Seok Jin
Choi, Chul Won
Kim, Byung Soo
Kim, Hyun Koo
Hong, Sunghoi
Park, Ji-ho
Choi, Yeonho
Park, Yong
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2883
引用
收藏
页数：2
相关论文
共 50 条
  • [41] TRANSFORMATION BY THE BCR-ABL GENE OF CHRONIC MYELOGENOUS LEUKEMIA - ROLES FOR MYC AND MAX
    SAWYERS, CL
    CALLAHAN, WA
    WITTE, ON
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 303 - 303
  • [42] Response to Imatinib Treatment in Chronic Myeloid Leukemia According to BCR-ABL Transcript
    Acosta Hernandez, Titania del Carmen
    Best Aguilera, Carlos Roberto
    Villela Martinez, Luis Mario
    Guzman Hernandez, Alicia Elizabeth
    Robles Rodriguez, Arianna
    Lopez Hernandez, Juan Carlos
    Gomez Vazquez, Oscar Rodrigo
    Rivera Mendoza, Laura Adriana
    Garcia Reyes, Barbara
    Gutierrez Alatorre, Aldo Fernando Adrian
    Calderon Valdez, Areli Sarai
    Visuetti Pimentel, Saribethe Mahely
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S242 - S243
  • [43] Chronic Myeloid Leukemia: Clinical Prestantation According to Bcr-Abl Transcript Variants
    Acosta Hernandez, Titania del Carmen
    Best Aguilera, Carlos Roberto
    Villela Martinez, Luis Mario
    Guzman Hernandez, Alicia Elizabeth
    Robles Rodriguez, Arianna
    Lopez Hernandez, Juan Carlos
    Gomez Vazquez, Oscar Rodrigo
    Rivera Mendoza, Laura Adriana
    Garcia Reyes, Barbara
    Gutierrez Alatorre, Aldo Fernando Adrian
    Calderon Valdez, Areli Sarai
    Visuetti Pimentel, Saribethe Mahely
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S243 - S243
  • [44] DETECTION OF BCR-ABL PROTEINS IN BLOOD-CELLS OF BENIGN PHASE CHRONIC MYELOGENOUS LEUKEMIA PATIENTS
    GUO, JQ
    WANG, JYJ
    ARLINGHAUS, RB
    CANCER RESEARCH, 1991, 51 (11) : 3048 - 3051
  • [45] Enhanced and Selective Killing of Chronic Myelogenous Leukemia Cells with an Engineered BCR-ABL Binding Protein and Imatinib
    Constance, Jonathan E.
    Woessner, David W.
    Matissek, Karina J.
    Mossalam, Mohanad
    Lim, Carol S.
    MOLECULAR PHARMACEUTICS, 2012, 9 (11) : 3318 - 3329
  • [46] BCR-ABL MAINTAINS RESISTANCE OF CHRONIC MYELOGENOUS LEUKEMIA-CELLS TO APOPTOTIC CELL-DEATH
    MCGAHON, A
    BISSONNETTE, R
    SCHMITT, M
    COTTER, KM
    GREEN, DR
    COTTER, TG
    BLOOD, 1994, 83 (05) : 1179 - 1187
  • [47] Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase
    Vigneri, P
    Wang, JYJ
    NATURE MEDICINE, 2001, 7 (02) : 228 - 234
  • [48] Cytogenetic response to autografting in chronic myelogenous leukemia correlates with the amount of BCR-ABL positive cells in the graft
    Corsetti, MT
    Lerma, E
    Dejana, A
    Cavaliere, M
    Figari, O
    Vassallo, F
    Abate, M
    Luchetti, S
    Piaggio, G
    Parodi, C
    Pira, GL
    Manca, F
    Carella, AM
    EXPERIMENTAL HEMATOLOGY, 2000, 28 (01) : 104 - 111
  • [49] Coordinate Modulation of Glycolytic Enzymes and OXPHOS by Imatinib in BCR-ABL Driven Chronic Myelogenous Leukemia Cells
    De Rosa, Viviana
    Monti, Marcello
    Terlizzi, Cristina
    Fonti, Rosa
    Del Vecchio, Silvana
    Iommelli, Francesca
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (13):
  • [50] Triptolide down-regulates bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cells
    Lou, YJ
    Jin, J
    LEUKEMIA & LYMPHOMA, 2004, 45 (02) : 373 - 376
12345